Graham Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.15M | Buy |
+50,000
| New | +$4.15M | 0.06% | 145 |
|
|
2024
Q2 | – | Sell |
-131,000
| Closed | -$12.4M | – | 1388 |
|
|
2024
Q1 | $12.4M | Buy |
131,000
+5,000
| +4% | +$474K | 0.23% | 49 |
|
|
2023
Q4 | $11.3M | Buy |
126,000
+26,000
| +26% | +$2.32M | 0.25% | 50 |
|
|
2023
Q3 | $7.3M | Buy |
100,000
+60,000
| +150% | +$4.38M | 0.17% | 83 |
|
|
2023
Q2 | $3.33M | Hold |
40,000
| – | – | 0.1% | 130 |
|
|
2023
Q1 | $3.05M | Hold |
40,000
| – | – | 0.09% | 144 |
|
|
2022
Q4 | $3.32M | Hold |
40,000
| – | – | 0.1% | 116 |
|
|
2022
Q3 | $3.17M | Sell |
40,000
-13,000
| -25% | -$1.03M | 0.13% | 107 |
|
|
2022
Q2 | $3.94M | Sell |
53,000
-40,000
| -43% | -$2.97M | 0.16% | 74 |
|
|
2022
Q1 | $8.36M | Buy |
+93,000
| New | +$8.36M | 0.29% | 36 |
|
|
2020
Q4 | – | Sell |
-55,000
| Closed | -$6.13M | – | 124 |
|
|
2020
Q3 | $6.13M | Buy |
55,000
+25,000
| +83% | +$2.79M | 0.21% | 47 |
|
|
2020
Q2 | $3.36M | Buy |
+30,000
| New | +$3.36M | 0.16% | 50 |
|